Hyper Insight™ – ICH
Hyper Insight AI Detection Solutions
Comprehensive Stroke AI Platform
AI software that triages suspected brain hemorrhage within seconds on non-contrast CT and alerts clinicians to potential findings.
Source: Clinical Study Report, Protocol No. SKAIICH-02, Hyper Insight-ICH FDA Clinical Performance Evaluation, Midstate Medical Center, USA.
Radiological computer-aided triage and notification software. Hyper Insight™ – ICH functions as a notification and triage tool — supporting, not replacing, medical judgment. Final diagnosis and treatment decisions remain the responsibility of qualified medical professionals.
(ICH, SAH, IPH, SDH, EDH)
Not cleared or approved by the US Food and Drug Administration (FDA). This software is not for clinical use in the United States and is provided for research, evaluation, and educational purposes only. The indication for use in pediatric patients (under 18 years of age) is currently under review by the Ministry of Food and Drug Safety (MFDS) and has not yet received regulatory approval. Clinical use in pediatric populations is subject to the outcome of this review.
AI-Assisted Reader Performance Improvement
Patient-level improvement when radiologists use Medical Insight+™ Brain Hemorrhage vs. unassisted reads.
+3.2% accuracy improvement among non-radiologists — the greatest gain across all reader groups.
ICC improved from Good (0.8475) to Excellent (0.9193). All metrics measured at patient level.
Source: Clinical Study Report, Protocol No. SKAIICH-01, Ver. 2.0, Seoul National University Hospital & Ajou University Hospital, Korea. CRIS: KCT0006734.
Top 15 Industry Features Avail.
Industry-standard integration capabilities available with PurpleAI deployments.